Weekly signal · CNC · Healthcare

Centene Corp (CNC) holds active weekly trend as volume confirmation stays uneven

A strong recovery in the managed-care insurer remains intact, but the supporting signals are not uniformly strong.

Centene Corp
Latest65.19 USD
1W move4.6%
Volume1.0x
TrendActive
Finance terminal and managed-care insurance documents representing Centene market activity.

Market update

What happened

Centene Corp (CNC) closed at 65.19 USD for the week ended June 12, up 4.6% on the week and 11.9% over four weeks.

In weekly context over 52 weeks, the trend state is active and Market Dynamics shows confirmation. The complication is participation: latest volume was close to its 13-week average, while Relative Strength sits at a measured 48.0.

Continue your research

Explore CNC across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

CNC coverage

Evidence context